Latest News
From the Journals
Registry data support lowering CRC screening age to 45
Existing research gaps on the rates of younger-onset colorectal neoplasia need to be addressed to support these recommendations.
From the Journals
Bowel ultrasound may overtake colonoscopy in Crohn’s
Bowel ultrasound may be the simple alternative to more costly and poorly tolerated colonoscopies.
Feature
Texas judge to rule on probes of transgender kids’ parents
A Texas judge will consider a request that she block state investigations of parents who get gender-transitioning care for their children.
Feature
Inside insulin (Part 2): Approaching a cure for type 1 diabetes?
Part 1 of this series examined the rivalry behind the discovery and use of insulin. In part 2, this news organization reviews the last century,...
Feature
Death of pig heart transplant patient is more a beginning than an end
The landmark case will have much to teach; still, it “turns back the clock” to a time when immunosuppression was especially intense “because we...
From the Journals
Verapamil might delay type 1 diabetes progression for at least 2 years
The oral blood pressure drug may delay type 1 diabetes progression, lower insulin requirements, and reduce proinflammatory cytokines.
Feature
Many rheumatologists in Ukraine become refugees amid chaos
Some are forced to leave the country or close their practices. Those staying are often using telemedicine or retraining to treat people outside...
From the Journals
Air trapping common in patients with long COVID
The reported findings “indicate a long-term impact on bronchiolar obstruction,” states Brett M. Elicker, MD.
From the Journals
CPAP has only small effect on metabolic syndrome
From the Journals
Lights on during sleep can play havoc with metabolism
If a light is needed for safety reasons, keep it as dim as possible and avoid exposure to blue or green light, but instead try red-amber colors....
From the Journals
Higher adalimumab dosing regimens may have benefit in ulcerative colitis
The findings also show that weekly adalimumab maintenance dosing “may be appropriate for some patients.”